Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05156424
What this trial is testing

A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer

Who this might be right for
ExerciseProstate Cancer
Kira Murphy 24
Testing effectiveness (Phase 2)Looking for participantsNCT07565285
What this trial is testing

The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III Melanoma

Who this might be right for
Melanoma Stage III
Primmune Therapeutics, Inc. 48
Not applicableStudy completedNCT05131113
What this trial is testing

Stratification of Patients in Oncogeriatrics and Personalization of Interventions

Who this might be right for
OncologySolid Tumor, Adult
Biogipuzkoa Health Research Institute 186
Not applicableStudy completedNCT02363608
What this trial is testing

Animal Assisted Activity Program on Patients and Staff on an Inpatient Surgical Oncology Unit

Who this might be right for
Postoperative Care
Memorial Sloan Kettering Cancer Center 146
Early research (Phase 1)UnknownNCT05114915
What this trial is testing

Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 144
Not applicableLooking for participantsNCT06445140
What this trial is testing

Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

Who this might be right for
Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 55
Not applicableStudy completedNCT01749774
What this trial is testing

Physical Activity and Testicular Cancer

Who this might be right for
Testicular Cancer
Oslo University Hospital 13
Not applicableWithdrawnNCT06610097
What this trial is testing

TNBC Gut Microbiota During Neoadjuvant Treatment

Who this might be right for
Breast CancerTriple Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Scripps Health
Not applicableStudy completedNCT03455608
What this trial is testing

PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer

Who this might be right for
Dysphagia
University Health Network, Toronto 952
Not applicableStudy completedNCT07591376
What this trial is testing

A Reminder App to Improve Physical Activity During Radiotherapy for Lung Cancer - a Pre-study in Healthy Volunteers

Who this might be right for
Lung Cancer
University Hospital Schleswig-Holstein 30
Early research (Phase 1)UnknownNCT04309968
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 186
Large-scale testing (Phase 3)UnknownNCT05429697
What this trial is testing

Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
SMT bio Co., Ltd. 128
Early research (Phase 1)Ended earlyNCT00383097
What this trial is testing

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma

Who this might be right for
Hodgkins LymphomaNon-Hodgkin Lymphoma
Baylor College of Medicine 6
Early research (Phase 1)Looking for participantsNCT06270706
What this trial is testing

PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumor
Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Ended earlyNCT05099549
What this trial is testing

Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

Who this might be right for
Squamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell LungColorectal Neoplasms+3 more
NKGen Biotech, Inc. 11
Not applicableStudy completedNCT04862325
What this trial is testing

SOPHIE Trial: Surgery in Ovarian Cancer With PreHabilitation In ERAS

Who this might be right for
Advanced Ovarian Cancer
Hospital Clinic of Barcelona 158
Testing effectiveness (Phase 2)Ended earlyNCT04157517
What this trial is testing

Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
NeoplasmsMelanoma
Teva Branded Pharmaceutical Products R&D LLC 45
Large-scale testing (Phase 3)Study completedNCT00276276
What this trial is testing

Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 141
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06952478
What this trial is testing

Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

Who this might be right for
Refractory or Relapsed Multiple Myeloma
Celltrion 486
Next Page